AI is an incredibly powerful tool that can empower complex data analysis and decision-making. To fully leverage the capabilities of AI, transparency and explainability are required to provide ...

The rising epidemic of diabetes is preventing sustainable development in India. Although well-established treatments and prevention options are available, the threat is still increasing at an alarming ...

Every journey has its ups and downs. But during trying times, a right partner can make all the difference. Sanofi has been a trusted health partner in India for over 60 years. Generations of Indians ...

Always use our prescription products under medical supervision.

This section contains abbreviated prescribing information/full prescribing information/leaflet of prescription product portfolio of Sanofi India Ltd, Sanofi-Synthelabo (India) Ltd. and Sanofi Pasteur ...

We make an upfront promise to our employees, patients, consumers, healthcare professionals, suppliers, contractors, government, investors through our Code of Ethics. Training employees, setting ...

Whether you're living with atopic dermatitis (AD), commonly referred to as eczema, or looking after someone who is, you're in the right place. Change AD is here to make understanding and managing your ...

Our commitment to support the social and economic development of the communities where we operate is built through partnerships with local stakeholders and the contribution of employees on behalf of ...

Commemorating 20-years of Sanofi Genzyme's presence in India Rare diseases are serious, chronic, debilitating and life-threatening diseases that require long-term and specialized management. Their ...

Shantha Biotechnics (an affiliate of Sanofi Vaccines) boasts of 2 state-of-the-art manufacturing facilities that manufacture and pack insulins and Vaccines at affordable prices, to serve the people of ...

Let’s face it – Atopic Dermatitis isn’t the easiest thing to understand, even if you’ve lived with it for years. So here’s an outline of what it is, and what makes it different from other types of ...

Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and ...